Persistent increase of cardiovascular and cerebrovascular events in COVID-19 patients: a 3-year population-based analysis.

Battistoni Allegra Massimo VolpeMorisco CarminePiccinocchi GaetanoPiccinocchi RobertoFini MassimoProietti StefaniaBonassi StefanoTrimarco Bruno

Published in: Cardiovascular research (2024)

The increase of cardiovascular risk associated with COVID-19 might be extended for years and not limited to the acute phase of the infection. This should promote the planning of longer follow up for COVID-19 patients to prevent and promptly manage the potential occurrence of major adverse cardiovascular and cerebrovascular events.

Keyphrases

sars cov
coronavirus disease
risk assessment
climate change
adverse drug